REQUEST A DEMO
Total
USD $0.00
Search more companies

Asociacion Cesarense De Neurocirugia-Acen Sas (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Asociacion Cesarense De Neurocirugia-Acen Sas Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Asociacion Cesarense De Neurocirugia-Acen Sas is an enterprise located in Colombia, with the main office in Valledupar. It operates in the Ambulatory Health Care Services sector. It was first established on May 21, 2013. There are currently 5 (2017) people employed by Asociacion Cesarense De Neurocirugia-Acen Sas. From the latest financial highlights, Asociacion Cesarense De Neurocirugia-Acen Sas reported a net sales revenue drop of 15.73% in 2023. Its’ total assets recorded a growth of 33.95%. The net profit margin of Asociacion Cesarense De Neurocirugia-Acen Sas increased by 11.07% in 2023.

Headquarters
Cl 16 15 71 Cons 304 301 306 Brr Santa
Valledupar; Cesar;

Contact Details: Purchase the Asociacion Cesarense De Neurocirugia-Acen Sas report to view the information.

Basic Information
Total Employees:
Purchase the Asociacion Cesarense De Neurocirugia-Acen Sas report to view the information.
Outstanding Shares:
Purchase the Asociacion Cesarense De Neurocirugia-Acen Sas report to view the information.
Incorporation Date:
May 21, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Asociacion Cesarense De Neurocirugia-Acen Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-15.73%
Total operating revenue
-15.73%
Operating profit (EBIT)
349.68%
EBITDA
254.36%
Net Profit (Loss) for the Period
245.86%
Total assets
33.95%
Total equity
27.72%
Operating Profit Margin (ROS)
18.1%
Net Profit Margin
11.07%
Return on Equity (ROE)
15.25%
Quick Ratio
-4.92%
Cash Ratio
0.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?